Alzheimer's drug fails to reduce significant agitation
A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to a new study conducted by researchers from the U.K., U.S. and Norway. This is the first randomized controlled ...
May 2, 2012
0
0